At the end of Q1 2025, 33 institutions reported holding Conduit Pharmaceuticals Inc. in their 13F filings, up 32 from Q4 2024. 32 opened new positions and 0 sold out. The largest holders were AQR Capital Management ($87K), State Street Corp. ($87K) and UBS Group AG ($62K). One famous investor held it Cliff Asness (0.0% of AQR Capital Management's portfolio).
Company
Conduit Pharmaceuticals Inc.
CUSIP
20678X205
Latest filing quarter
Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
Institutions
Total Value
New Positions
32
$386K
Exits
0
$0
All 13F filers, Q4 2024 → Q1 2025: 494,267 shares bought and 2,001 shares sold, net +492,266 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
"% of holder's portfolio" is CONDUIT PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Conduit Pharmaceuticals Inc. the manager owns.